Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Cognition and Motor Learning Post-stroke
for
Stroke, CVA (Cerebrovascular Accident)
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 45 - 70+
Code: NCT04829071
Early Phase 1, Recruiting
The K-Map Study, Global Prevalence of KC
for
Keratoconus
Location: Los Angeles CA
Sponsor: University Hospital, Geneva
Sex: All
Age: 6 - 23
Code: NCT03115710
Recruiting
New
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
for
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities,
Location: Los Angeles CA, Bellflower CA, Anaheim CA, Orange CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07615049
Phase 3, Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Los Angeles CA, Newport Beach CA, Clovis CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase 1, Phase 2, Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: Los Angeles CA, Orange CA, Irvine CA, Santa Maria CA,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Los Angeles CA, Fullerton CA, Scottsdale AZ, Chicago IL,
Location: Los Angeles CA, Orange CA, Dallas TX, Houston TX,
Sponsor: KaliVir Immunotherapeutics
Sex: All
Age: 18+
Code: NCT06444815
Phase 1, Recruiting
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
for
Peripheral T-cell Lymphoma
Location: Los Angeles CA, Gilbert AZ, Dallas TX, Westwood KS,
Sponsor: CerRx, Inc.
Sex: All
Age: 18+
Code: NCT02495415
Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Los Angeles CA, Orange CA, La Jolla CA, Phoenix AZ,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase 1, Recruiting
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Los Angeles CA, Fullerton CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06336902
Phase 1, Recruiting
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Aurora CO, Columbus OH, Orlando FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06233942
Phase 1, Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
for
Extensive Stage Small Cell Lung Cancer
Location: Los Angeles CA, Seattle WA, Sioux Falls SD, Houston TX,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06598306
Phase 1, Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Los Angeles CA, Newport Beach CA, San Francisco CA,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase 1, Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 70+
Code: NCT04333706
Phase 1, Phase 2, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Los Angeles CA, Duarte CA, Beverly Hills CA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase 3, Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Location: Los Angeles CA, Stanford CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06060613
Phase 1, Phase 2, Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Los Angeles CA, Vancouver, San Antonio TX, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06827613
Phase 1, Phase 2, Recruiting
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
for
Head and Neck Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06420219
Recruiting
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for
Head and Neck Squamous Cell Carcinoma
Location: Los Angeles CA, Duarte CA, Palo Alto CA, Santa Rosa CA,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06163534
Recruiting
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
for
Advanced Adenocarcinoma
Location: Los Angeles CA, Irvine CA, Seattle WA, Chicago IL,